Praxis Precision Medicines, Inc. (PRAX)
NASDAQ: PRAX · IEX Real-Time Price · USD
45.39
+0.18 (0.40%)
May 17, 2024, 4:00 PM EDT - Market closed

PRAX Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year 202320222021202020192018
Revenue
2.4500000
Gross Profit
2.4500000
Selling, General & Admin
42.0559.9547.0816.996.233.9
Research & Development
86.77155.04120.2644.9829.5618.82
Operating Expenses
128.82214.99167.3361.9735.7922.72
Operating Income
-126.37-214.99-167.33-61.97-35.79-22.72
Interest Expense / Income
000000.13
Other Expense / Income
-3.1-0.96-0.27-0.14-0.193.56
Pretax Income
-123.28-214.03-167.06-61.83-35.6-26.4
Income Tax
000-0.01-0.080.13
Net Income
-123.28-214.03-167.06-61.82-35.51-26.54
Preferred Dividends
0008.55.172.3
Net Income Common
-123.28-214.03-167.06-70.32-40.68-29.22
Shares Outstanding (Basic)
733100
Shares Outstanding (Diluted)
733100
Shares Change
114.58%8.58%374.34%485.12%17.88%-
EPS (Basic)
-18.69-69.65-59.10-117.90-399.00-337.80
EPS (Diluted)
-18.69-69.65-59.10-117.90-399.00-337.80
Free Cash Flow
-111.19-185.49-125.6-52.62-33.52-20.78
Free Cash Flow Per Share
-16.86-60.36-44.38-88.19-328.74-240.25
Gross Margin
100.00%-----
Operating Margin
-5164.41%-----
Profit Margin
-5037.88%-----
Free Cash Flow Margin
-4543.77%-----
EBITDA
-122.01-212.86-165.47-61.08-34.92-26.27
EBITDA Margin
-4986.02%-----
Depreciation & Amortization
1.271.171.590.750.680
EBIT
-123.28-214.03-167.06-61.83-35.6-26.28
EBIT Margin
-5037.88%-----
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).